{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:18:46Z","timestamp":1769267926353,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07488-5","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:43:39Z","timestamp":1753868619000},"page":"968-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vasculature cast sign on 18F-FDG PET\/CT: a specific imaging marker for pediatric T-lymphoblastic lymphoma"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0899-657X","authenticated-orcid":false,"given":"Haoyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2068-5129","authenticated-orcid":false,"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6571-654X","authenticated-orcid":false,"given":"Suyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"7488_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/cncy.21584","volume":"123","author":"P Bhaker","year":"2015","unstructured":"Bhaker P, et al. Precursor T-lymphoblastic lymphoma: speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry. Cancer Cytopathol. 2015;123:557\u201365. https:\/\/doi.org\/10.1002\/cncy.21584.","journal-title":"Cancer Cytopathol"},{"key":"7488_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","volume":"79","author":"S Cortelazzo","year":"2011","unstructured":"Cortelazzo S, et al. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2011;79:330\u201343. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.12.003.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7488_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2023.101449","volume":"36","author":"WC Temple","year":"2023","unstructured":"Temple WC, et al. Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults. Best Pract Res Clin Haematol. 2023;36: 101449. https:\/\/doi.org\/10.1016\/j.beha.2023.101449.","journal-title":"Best Pract Res Clin Haematol"},{"key":"7488_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/bjh.12460","volume":"162","author":"AM Termuhlen","year":"2013","unstructured":"Termuhlen AM, et al. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the children\u2019s oncology group. Br J Haematol. 2013;162:792\u2013801. https:\/\/doi.org\/10.1111\/bjh.12460.","journal-title":"Br J Haematol"},{"key":"7488_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01168-x","volume":"24","author":"T Intermesoli","year":"2022","unstructured":"Intermesoli T, et al. Lymphoblastic lymphoma: a concise review. Curr Oncol Rep. 2022;24:1\u201312. https:\/\/doi.org\/10.1007\/s11912-021-01168-x.","journal-title":"Curr Oncol Rep"},{"key":"7488_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","volume":"113","author":"S Cortelazzo","year":"2017","unstructured":"Cortelazzo S, et al. Lymphoblastic lymphoma. Crit rev oncol hematol. Nucl Med Commun. 2017;113:304\u201317. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.020.","journal-title":"Nucl Med Commun"},{"key":"7488_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bjh.12042","volume":"159","author":"JL Patel","year":"2012","unstructured":"Patel JL, et al. The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a children\u2019s oncology group report. Br J Haematol. 2012;159:454\u201361. https:\/\/doi.org\/10.1111\/bjh.12042.","journal-title":"Br J Haematol"},{"key":"7488_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","volume":"113","author":"S Cortelazzo","year":"2017","unstructured":"Cortelazzo S, et al. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304\u201317. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.020.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7488_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.11622\/smedj.2019139","volume":"61","author":"CSK Reddy","year":"2020","unstructured":"Reddy CSK, et al. A simplified approach for anaesthetic management of diagnostic procedures in children with anterior mediastinal mass. Singap Med J. 2020;61:308\u201311. https:\/\/doi.org\/10.11622\/smedj.2019139.","journal-title":"Singap Med J"},{"key":"7488_CR10","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00247-022-05409-4","volume":"52","author":"G Sreedher","year":"2022","unstructured":"Sreedher G, et al. Pediatric mediastinal masses. Pediatr Radiol. 2022;52:1935\u201347. https:\/\/doi.org\/10.1007\/s00247-022-05409-4.","journal-title":"Pediatr Radiol"},{"key":"7488_CR11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232650","volume":"314","author":"D Stoevesandt","year":"2025","unstructured":"Stoevesandt D, et al. CT, MRI, and FDG PET\/CT in the assessment of lymph node involvement in pediatric Hodgkin lymphoma: an expert consensus definition by an international collaboration on staging evaluation and response criteria harmonization for children, adolescent, and young adult Hodgkin lymphoma (SEARCH for CAYAHL). Radiology. 2025;314: e232650. https:\/\/doi.org\/10.1148\/radiol.232650.","journal-title":"Radiology"},{"issue":"Suppl 4","key":"7488_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29968","volume":"70","author":"J Mhlanga","year":"2023","unstructured":"Mhlanga J, et al. Imaging recommendations in pediatric lymphoma: a COG diagnostic imaging committee\/spr oncology committee white paper. Pediatr Blood Cancer. 2023;70(Suppl 4): e29968. https:\/\/doi.org\/10.1002\/pbc.29968.","journal-title":"Pediatr Blood Cancer"},{"key":"7488_CR13","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368. https:\/\/doi.org\/10.1200\/jco.2013.54.8800.","journal-title":"J Clin Oncol"},{"key":"7488_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2967\/jnumed.118.222299","volume":"60","author":"JJ Cerci","year":"2019","unstructured":"Cerci JJ, et al. Is true whole-body (18)F-FDG PET\/CT required in pediatric lymphoma?? An IAEA multicenter prospective study. J Nucl Med. 2019;60:1087\u201393. https:\/\/doi.org\/10.2967\/jnumed.118.222299.","journal-title":"J Nucl Med"},{"key":"7488_CR15","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/jco.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32:3048\u201358. https:\/\/doi.org\/10.1200\/jco.2013.53.5229.","journal-title":"J Clin Oncol"},{"key":"7488_CR16","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.Can-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-0125.","journal-title":"Cancer Res"},{"key":"7488_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, et al. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"7488_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.271.9.703","volume":"271","author":"R Jaeschke","year":"1994","unstructured":"Jaeschke R, et al. Users\u2019 guides to the medical literature. III. How to use an Article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based medicine working group. JAMA. 1994;271:703\u20137. https:\/\/doi.org\/10.1001\/jama.271.9.703.","journal-title":"JAMA"},{"key":"7488_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.prp.2007.07.006","volume":"203","author":"C Tataroglu","year":"2007","unstructured":"Tataroglu C, et al. Fibrosis in Hodgkin and non-Hodgkin lymphomas. Pathol Res Pract. 2007;203:725\u201330. https:\/\/doi.org\/10.1016\/j.prp.2007.07.006.","journal-title":"Pathol Res Pract"},{"key":"7488_CR20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/jir.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, et al. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res. 2022;15:3083\u201394. https:\/\/doi.org\/10.2147\/jir.S350109.","journal-title":"J Inflamm Res"},{"key":"7488_CR21","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220749","volume":"306","author":"Y Mori","year":"2023","unstructured":"Mori Y, et al. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology. 2023;306: e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","journal-title":"Radiology"},{"key":"7488_CR22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2967\/jnumed.123.265530","volume":"64","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Fibroblast activation protein and glycolysis in lymphoma diagnosis: comparison of (68)Ga-FAPI PET\/CT and (18)F-FDG PET\/CT. J Nucl Med. 2023;64:1399\u2013405. https:\/\/doi.org\/10.2967\/jnumed.123.265530.","journal-title":"J Nucl Med"},{"key":"7488_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, et al. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014;14:517\u201334. https:\/\/doi.org\/10.1038\/nrc3774.","journal-title":"Nat Rev Cancer"},{"key":"7488_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4143\/crt.2020.123","volume":"53","author":"X Feng","year":"2021","unstructured":"Feng X, et al. Baseline total metabolic tumor volume and total lesion Glycolysis measured on 18F-FDG PET-CT predict outcomes in T-Cell lymphoblastic lymphoma. Cancer Res Treat. 2021;53:837\u201346. https:\/\/doi.org\/10.4143\/crt.2020.123.","journal-title":"Cancer Res Treat"},{"key":"7488_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.remnie.2020.12.010","volume":"41","author":"J Yang","year":"2022","unstructured":"Yang J, et al. The role of (18)F-FDG PET\/CT metabolic parameters in pediatric lymphoblastic lymphoma. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022;41:91\u20139. https:\/\/doi.org\/10.1016\/j.remnie.2020.12.010.","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"7488_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/1471-2407-12-586","volume":"12","author":"S Hartmann","year":"2012","unstructured":"Hartmann S, et al. GLUT1 expression patterns in different hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer. 2012;12:586. https:\/\/doi.org\/10.1186\/1471-2407-12-586.","journal-title":"BMC Cancer"},{"key":"7488_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/mnm.0000000000000496","volume":"37","author":"H Huang","year":"2016","unstructured":"Huang H, et al. Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma. Nucl Med Commun. 2016;37:689\u201398. https:\/\/doi.org\/10.1097\/mnm.0000000000000496.","journal-title":"Nucl Med Commun"},{"key":"7488_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/10428194.2013.807509","volume":"55","author":"Y Hirose","year":"2014","unstructured":"Hirose Y, et al. Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2014;55:520\u20135. https:\/\/doi.org\/10.3109\/10428194.2013.807509.","journal-title":"Leuk Lymphoma"},{"key":"7488_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7488_CR30","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00277-022-04988-4","volume":"101","author":"X Tan","year":"2022","unstructured":"Tan X, et al. Clinical and prognostic role of 2-[(18)F]FDG PET\/CT and sarcopenia in treatment-na\u00efve patients with T-cell lymphoblastic lymphoma. Ann Hematol. 2022;101:2699\u2013709. https:\/\/doi.org\/10.1007\/s00277-022-04988-4.","journal-title":"Ann Hematol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07488-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:44Z","timestamp":1769222804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7488"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07488-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and the requirement for informed consent was waived (No. XHEC-D-2025-061).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the nature of the retrospective study, the need for informed consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The whole study was proceeded respecting the principles of the Declaration of Helsinki. General consent from the institution was approved by each patient participating in this study agreeing a retrospective use of their medical history, health-related information and images for clinical research. The Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine approved the research protocol.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}